Three-dimensional quantitative structure-activity relationship analyses of a series of butenolide ETA antagonists

被引:0
|
作者
Zhu, LL [1 ]
Xu, XJ [1 ]
机构
[1] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China
关键词
CoMFA; CoMSIA; 3D-QSAR; butenolide ETA selective antagonists; all-space search;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Two kinds of Three-dimensional Quantitative Structure-activity Relationship (3D-QSAR) methods, comparative molecular field analysis (CoNWA) and comparative molecular similarity indices analysis (CoMSIA), were applied to analyze the structure-activity relationship of a series of 63 butenolkle ETA selective antagonists with respect to thew inhibition against human ETA receptor. The CoNWA and CoMSIA models were developed for the conceivable alignment of the molecules based on a template structure from the crystallized data. The statistical results from the initial orientation of the aligned molecules show that the 3D-QSAR model from CoNWA ( q(2) = 0.543) is Obviously Superior to that from the Conventional CoMSIA (q(2) = 0.407). In order to refine the model, all-space search (ASS) was applied to minimize the field sampling process. By rotating and translating the molecular aggregate within the grid systematically, all the possible samplings of the molecular fields were tested and subsequently the one with the highest q(2) was picked out. The comparison of the sensitivity of CoMFA and CoMSIA to different space orientation shows that the CoMFA q(2) Values are more sensitive to the translations and rotations of the aligned molecules with respect to the lattice than those of CoMSIA. The best CoMFA model from ASS was further refined by the region focused technique. The high quality of the best model is indicated by the high cross-validated correlation and the prediction on the external test set. The CoMFA coefficient contour plots identify several key features dud explain the wide range of activities, which may help us to design new effective ETA selective antagonists.
引用
收藏
页码:261 / 269
页数:9
相关论文
共 50 条
  • [31] Three-dimensional quantitative structure-activity relationships for androgen receptor ligands
    Waller, CL
    Juma, BW
    Gray, LE
    Kelce, WR
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 137 (02) : 219 - 227
  • [32] Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors
    Oprea, TI
    Garcia, AE
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1996, 10 (03) : 186 - 200
  • [33] Two- and three-dimensional quantitative structure-activity relationships for a series of purine nucleoside phosphorylase inhibitors
    Castilho, MS
    Postigo, MP
    de Paula, CBV
    Montanari, CA
    Oliva, G
    Andricopulo, AD
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (02) : 516 - 527
  • [34] Three-dimensional quantitative structure-activity relationship analyses of peptide substrates of the mammalian H+/peptide cotransporter PEPT1
    Gebauer, S
    Knütter, I
    Hartrodt, B
    Brandsch, M
    Neubert, K
    Thondorf, I
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (26) : 5725 - 5734
  • [35] Quantitative structure-activity studies of insect growth regulators XIV. Three-dimensional quantitative structure-activity relationship of ecdysone agonists including dibenzoylhydrazine analogs
    Nakagawa, Y
    Hattori, K
    Shimizu, B
    Akamatsu, M
    Miyagawa, H
    Ueno, T
    PESTICIDE SCIENCE, 1998, 53 (04): : 267 - 277
  • [36] Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody
    Paula, S
    Tabet, MR
    Farr, CD
    Norman, AB
    Ball, WJ
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (01) : 133 - 142
  • [37] Three-dimensional Quantitative Structure-activity Relationship Models of HIV-1 Integrase Inhibitors of DKAs
    张美青
    赵文娜
    陆绍永
    结构化学, 2012, 31 (12) : 1769 - 1781
  • [38] Three-dimensional quantitative structure-activity, relationship modeling of γ-secretase inhibitors using molecular field analysis
    Sammi, Tarnvir
    Silalkari, Om
    Ravikumar, Muttineni
    CHEMICAL BIOLOGY & DRUG DESIGN, 2008, 71 (02) : 155 - 166
  • [39] Three-dimensional quantitative structure-activity relationship for inhibitors of cytochrome P4502C9
    Jones, JP
    He, MX
    Trager, WF
    Rettie, AE
    DRUG METABOLISM AND DISPOSITION, 1996, 24 (01) : 1 - 6
  • [40] Polarizability fields for use in three-dimensional quantitative structure-activity relationship (3D-QSAR)
    Bradley, M
    Waller, CL
    JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2001, 41 (05): : 1301 - 1307